ARCHIVES

Phase II Study: Proton Therapy Can Have Similar Success Rate, Smaller Level of Risk in Treatment of Hodgkin Lymphoma

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approves Votrient For Soft Tissue Sarcomas

April 27, 2012

Huebner Retires, Named Scientist Emeritus

November 19, 1982

Dana-Farber Opens Imaging Center

May 8, 2009

Breast Cancer Overview Correlates Incidence Increase With Other Factors

July 29, 1988

New NIH Chief Splits with Predecessors, HEW Brass, Opposes “Balance,” Likes Cancer Program

October 24, 1975

AZT Trial Unblended, Controls Get Drugs; Gallo, Essex Win Lasker With Montagnier

September 26, 1986